Advertisement
U.S. markets open in 2 hours 2 minutes

Ayala Pharmaceuticals, Inc. (ADXS)

Other OTC - Other OTC Delayed Price. Currency in USD
0.5974-0.0226 (-3.65%)
At close: 11:27AM EDT
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
Total Revenue
1,733
3,506
3,708
Cost of Revenue
1,643
3,506
3,708
Gross Profit
90
0
0
Operating Expense
37,632
39,218
29,777
Operating Income
-37,542
-39,218
-29,777
Net Non Operating Interest Income Expense
-224
-260
56
Pretax Income
-37,766
-39,478
-29,721
Tax Provision
708
776
425
Net Income Common Stockholders
-38,474
-40,254
-30,146
Diluted NI Available to Com Stockholders
-38,474
-40,254
-30,146
Basic EPS
-2.51
-2.80
-3.06
Diluted EPS
-2.51
-2.80
-3.06
Basic Average Shares
15,325
14,399
9,861
Diluted Average Shares
15,325
14,399
9,861
Total Operating Income as Reported
-37,542
-39,218
-29,777
Total Expenses
39,275
42,724
33,485
Net Income from Continuing & Discontinued Operation
-38,474
-40,254
-30,146
Normalized Income
-38,474
-40,254
-30,146
Interest Income
-
-
56
Interest Expense
-
260
-
Net Interest Income
-224
-260
56
EBIT
-37,542
-39,218
-29,777
EBITDA
-37,393
-39,050
-29,595
Reconciled Cost of Revenue
1,643
3,506
3,708
Reconciled Depreciation
149
168
182
Net Income from Continuing Operation Net Minority Interest
-38,474
-40,254
-30,146
Normalized EBITDA
-37,393
-39,050
-29,595
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0